 | | PRD_002277 | | Name: | N-{(2S,4R)-2-[(1R)-3-amino-1-({N-[(2R)-2-{(1R)-1-[(N-{(2S)-2-[(1S)-3-amino-1-({N-[(3S,6R)-3-(3-amino-3-oxopropyl)-6-(hydroxymethyl)-5-oxo-3,4,5,6-tetrahydropyrazin-2-yl]-L-seryl-L-prolylglycyl}amino)-3-oxopropyl]-2,3-dihydro-1,3-thiazole-4-carbonyl}-L-alanyl)amino]-2-hydroxyethyl}-2,3-dihydro-1,3-thiazole-4-carbonyl]-L-seryl}amino)-3-oxopropyl]-1,3-oxazolidine-4-carbonyl}-L-alanyl-L-seryl-N-{(1S)-3-amino-1-[(2S)-4-{[(2S,3S)-3-hydroxy-1-oxobutan-2-yl]carbamoyl}-2,3-dihydro-1,3-thiazol-2-yl]-3-oxopropyl}-L-alaninamide | | Formula: | C64 H93 N23 O25 S3 | | Definition date: | 2017-08-30 | | Last modified: | 2017-12-15 |
|
 | | PRD_002263 | | Name: | N-[(1S)-1-cyclohexyl-2-{[3-(morpholin-4-yl)propanoyl]amino}ethyl]-N~2~-propanoyl-3-[6-(propan-2-yl)-1,3-benzothiazol-2-yl]-L-alaninamide | | Formula: | C31 H47 N5 O4 S | | Definition date: | 2017-11-01 | | Last modified: | 2017-11-01 |
|
 | | PRD_001137 | | Name: | (4S,6aR,7aS)-5-{(2S)-2-cyclohexyl-2-[(N-methyl-L-alanyl)amino]acetyl}-N-[(4R)-3,4-dihydro-2H-chromen-4-yl]octahydro-1H-cyclopropa[4,5]pyrrolo[1,2-a]pyrazine-4-carboxamide | | Formula: | C30 H43 N5 O4 | | Definition date: | 2013-08-28 | | Last modified: | 2017-09-14 |
|
 | | PRD_001138 | | Name: | (3S,7R,8aR)-2-{(2S)-2-(4,4-difluorocyclohexyl)-2-[(N-methyl-L-alanyl)amino]acetyl}-N-[(4R)-3,4-dihydro-2H-chromen-4-yl]-7-ethoxyoctahydropyrrolo[1,2-a]pyrazine-3-carboxamide | | Formula: | C31 H45 F2 N5 O5 | | Definition date: | 2013-08-07 | | Last modified: | 2017-09-14 |
|
 | | PRD_001139 | | Name: | (3S,8aR)-2-{(2S)-2-cyclohexyl-2-[(N-methyl-L-alanyl)amino]acetyl}-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]octahydropyrrolo[1,2-a]pyrazine-3-carboxamide | | Formula: | C30 H45 N5 O3 | | Definition date: | 2013-08-07 | | Last modified: | 2017-09-14 |
|
 | | PRD_001140 | | Name: | N-(4-fluorobenzoyl)-L-gamma-glutamyl-5-{[(S)-{[(1S)-1,3-dicarboxypropyl]amino}(hydroxy)phosphoryl]oxy}-L-norvaline | | Formula: | C22 H29 F N3 O13 P | | Definition date: | 2014-12-31 | | Last modified: | 2017-09-14 |
|
 | | PRD_001141 | | Name: | (3S,8aR)-N-((R)-chroman-4-yl)-2-((S)-2-cyclohexyl-2-((S)-2-(methylamino)propanamido)acetyl)octahydropyrrolo[1,2-a]pyrazine-3-carboxamide | | Formula: | C29 H43 N5 O4 | | Definition date: | 2013-08-28 | | Last modified: | 2017-09-14 |
|
 | | PRD_001160 | | Name: | D-phenylalanyl-N-[(3S)-6-carbamimidamido-1-chloro-2-oxohexan-3-yl]-L-phenylalaninamide | | Formula: | C25 H33 Cl N6 O3 | | Definition date: | 2013-09-05 | | Last modified: | 2017-09-14 |
|
 | | PRD_001161 | | Name: | N-hexanoyl-L-valyl-N~1~-[(4S,5S,6R)-5-hydroxy-2,6-dimethyloctan-4-yl]-N~5~,N~5~-dimethyl-L-glutamamide | | Formula: | C28 H54 N4 O5 | | Description: | Originated from (S)-N1-((S,Z)-2,6-dimethyl-5-oxooct-6-en-4-yl)-2-((S)-2-hexanamido-3-methylbutanamido)-N5,N5-dimethylpentanediamide that reacts with N-terminal Thr of the protein, opening double bonds of the original compound and making two covalent linkages with the amino group and side chain hydroxyl of the Thr. The PRD represents the bound form. | | Definition date: | 2014-07-02 | | Last modified: | 2017-09-14 |
|
 | | PRD_001163 | | Name: | N-(4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-gamma-glutamyl-L-gamma-glutamyl-L-gamma-glutamyl-L-glutamic acid | | Formula: | C34 H40 N10 O15 | | Definition date: | 2014-06-18 | | Last modified: | 2017-09-14 |
|
 | | PRD_001164 | | Name: | N-(4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-gamma-glutamyl-L-gamma-glutamyl-L-glutamic acid | | Formula: | C29 H33 N9 O12 | | Definition date: | 2014-06-18 | | Last modified: | 2017-09-14 |
|
 | | PRD_001165 | | Name: | N-(4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-gamma-glutamyl-L-glutamic acid | | Formula: | C24 H26 N8 O9 | | Definition date: | 2014-06-18 | | Last modified: | 2017-09-14 |
|
 | | PRD_001174 | | Name: | (2S)-2-{[(2R,5S)-5-{[(2S,3S)-2-{[(2S,3R)-2-(acetylamino)-3-hydroxybutanoyl]amino}-3-methylpentanoyl]amino}-2-butyl-4-oxononanoyl]amino}-N~1~-[(2S)-1-amino-5-carbamimidamido-1-oxopentan-2-yl]pentanediamide | | Formula: | C36 H66 N10 O9 | | Definition date: | 2013-10-16 | | Last modified: | 2017-09-14 |
|
 | | PRD_001175 | | Name: | P-((((benzyloxy)carbonyl)amino)methyl)-N-((S)-1-(isobutylamino)-4-methyl-1-oxopentan-2-yl)phosphonamidic acid | | Formula: | C19 H32 N3 O5 P | | Definition date: | 2014-04-02 | | Last modified: | 2017-09-14 |
|
 | | PRD_001177 | | Name: | P-((((benzyloxy)carbonyl)amino)methyl)-N-((S)-4-methyl-1-oxo-1-(phenethylamino)pentan-2-yl)phosphonamidic acid | | Formula: | C23 H32 N3 O5 P | | Definition date: | 2014-04-02 | | Last modified: | 2017-09-14 |
|
 | | PRD_001178 | | Name: | P-((((benzyloxy)carbonyl)amino)methyl)-N-((S)-4-methyl-1-oxo-1-(propylamino)pentan-2-yl)phosphonamidic acid | | Formula: | C18 H30 N3 O5 P | | Definition date: | 2014-04-02 | | Last modified: | 2017-09-14 |
|
 | | PRD_001179 | | Name: | P-((((benzyloxy)carbonyl)amino)methyl)-N-((S)-4-methyl-1-(((S)-2-methylbutyl)amino)-1-oxopentan- 2-yl)phosphonamidic
acid | | Formula: | C20 H34 N3 O5 P | | Definition date: | 2014-04-02 | | Last modified: | 2017-09-14 |
|
 | | PRD_001180 | | Name: | P-((((benzyloxy)carbonyl)amino)methyl)-N-((S)-1-((3,3-dimethylbutyl)amino)-4-methyl-1-oxopentan-2-yl)phosphonamidic
acid | | Formula: | C21 H36 N3 O5 P | | Definition date: | 2014-04-02 | | Last modified: | 2017-09-14 |
|
 | | PRD_001182 | | Name: | P-((((benzyloxy)carbonyl)amino)methyl)-N-((S)-4-methyl-1-(neopentylamino)-1-oxopentan-2-yl)phosphonamidic acid | | Formula: | C20 H34 N3 O5 P | | Definition date: | 2014-04-02 | | Last modified: | 2017-09-14 |
|
 | | PRD_001183 | | Name: | P-((((benzyloxy)carbonyl)amino)methyl)-N-((S)-1-(isopentylamino)-4-methyl-1-oxopentan-2-yl)phosphonamidic acid | | Formula: | C20 H34 N3 O5 P | | Definition date: | 2014-04-02 | | Last modified: | 2017-09-14 |
|
 | | PRD_001200 | | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-{(1R,2S)-1-hydroxy-4-methyl-1-[(2R)-2-methyloxiran-2-yl]pentan-2-yl}-L-leucinamide | | Formula: | C29 H47 N3 O6 | | Definition date: | 2014-02-12 | | Last modified: | 2017-09-14 |
|
 | | PRD_001205 | | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2S,3S)-2-hydroxy-5-methyl-1-oxo-1-(phenylamino)hexan-3-yl]-L-leucinamide | | Formula: | C33 H48 N4 O6 | | Definition date: | 2014-02-12 | | Last modified: | 2017-09-14 |
|
 | | PRD_001206 | | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(3S)-5-methyl-1-(methylsulfonyl)hexan-3-yl]-L-leucinamide | | Formula: | C28 H47 N3 O6 S | | Definition date: | 2014-02-12 | | Last modified: | 2017-09-14 |
|
 | | PRD_001207 | | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2R,3S)-1,2-dihydroxy-5-methylhexan-3-yl]-L-leucinamide | | Formula: | C27 H45 N3 O6 | | Definition date: | 2014-02-12 | | Last modified: | 2017-09-14 |
|
 | | PRD_001210 | | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2S)-1-hydroxy-4-methylpentan-2-yl]-L-leucinamide | | Formula: | C26 H43 N3 O5 | | Definition date: | 2014-02-12 | | Last modified: | 2017-09-14 |
|
